Welcome to Ibere Pharmaceuticals
   
Ibere Pharmaceuticals
  • Home
  • Our Team
  • Investors
    • Stock Quote
    • Governance Documents
    • SEC.GOV Filings
    • IBER.U Quotes
  • News
  • Contact

Recent Posts

  • Ibere Pharmaceuticals Announces the Separate Trading of its Class A Ordinary Shares
    April 19, 2021

    Ibere Pharmaceuticals Announces the Separate Trading of its Class A Ordinary Shares and Redeemable Warrants Commencing April 19, 2021

  • Ibere Pharmaceuticals Announces Closing of $138,000,000 Initial Public Offering
    March 2, 2021

    Ibere Pharmaceuticals Announces Closing of $138,000,000 Initial Public Offering

  • Philadelphia-based blank check company Ibere Pharmaceuticals completes $120M IPO
    March 1, 2021

    Philadelphia-based blank check company Ibere Pharmaceuticals completes $120M IPO

About Ibere

Providing New Beginnings to Branded Pharmaceutical Portfolios with a Focus on Margin Improvement and Global Market Growth.


Subscribe Today

Subscribe to our newsletter.


    Contact Ibere

    If you have any questions or comments please feel free to contact us using one of the links below:
    + 1 (267) 765-3235

    www.iberepharma.com

    info@iberepharma.com

    Ibere Pharmaceuticals © 2021. All rights reserved.

    • Homepage
    • Our Team
    • Investors
    • News
    • Contact